Texas Oncology Foundation Inc
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$3,549,379
Cash & Equivalents
73%
Receivables (Non-Related)
22%
Other Assets
4%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Liabilities in 2024 (Year End)
$138,959
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$2,622,184
$2,593,731
-1%
Receivables (Non-Related)
$78,529
$793,890
+911%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$2,612
$15,648
+499%
Investments
$0
$0
-
Property, Plant, & Equipment (net)
$7,980
$3,250
-59%
Other Assets
$0
$142,860
-
Total Assets
$2,711,305
$3,549,379
+31%
Liabilities
2023
2024
Change
Payables & Accruals
$98,225
$138,959
+41%
Grants Payable
$0
$0
-
Deferred Revenue
$0
$0
-
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$0
$0
-
Total Liabilities
$98,225
$138,959
+41%
Net assets
2023
2024
Change
Restricted Net Assets
$2,613,220
$3,679,200
+41%
Unrestricted Net Assets
-$140
-$268,780
-191886%
Net assets
2023
2024
Change
Net assets
+$2,613,080
+$3,410,420
+31%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)